Literature DB >> 2133612

Diaphragmatic weakness in hereditary motor and sensory neuropathy.

R Hardie1, A E Harding, N Hirsch, C Gelder, A D Macrae, P K Thomas.   

Abstract

Six patients severely affected by hereditary motor and sensory neuropathy (HMSN), four type I and two type II, had clinical evidence of diaphragmatic weakness. One presented with cardiorespiratory failure secondary to nocturnal hypoventilation, and three others were unable to lie flat because of dyspnoea. Diaphragmatic paralysis should be considered as a cause of respiratory or cardiac failure in cases of HMSN.

Entities:  

Mesh:

Year:  1990        PMID: 2133612      PMCID: PMC1014177          DOI: 10.1136/jnnp.53.4.348

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

1.  Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies.

Authors:  P J Dyck; E H Lambert
Journal:  Arch Neurol       Date:  1968-06

2.  Enigmatic dyspnoea: an unusual presentation of motor-neurone disease.

Authors:  S Nightingale; D Bates; D E Bateman; P Hudgson; D A Ellis; G J Gibson
Journal:  Lancet       Date:  1982-04-24       Impact factor: 79.321

3.  Acid maltase deficiency in adults. Diagnosis and management in five cases.

Authors:  P S Trend; C M Wiles; G T Spencer; J A Morgan-Hughes; B D Lake; A D Patrick
Journal:  Brain       Date:  1985-12       Impact factor: 13.501

4.  Autosomal recessive forms of hereditary motor and sensory neuropathy.

Authors:  A E Harding; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-08       Impact factor: 10.154

5.  Diaphragmatic dysfunction in siblings with hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease).

Authors:  C K Chan; V Mohsenin; J Loke; J Virgulto; M L Sipski; R Ferranti
Journal:  Chest       Date:  1987-04       Impact factor: 9.410

6.  Diaphragm function and alveolar hypoventilation.

Authors:  J Davis; M Goldman; L Loh; M Casson
Journal:  Q J Med       Date:  1976-01

7.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

8.  The late sequelae of poliomyelitis.

Authors:  R S Howard; C M Wiles; G T Spencer
Journal:  Q J Med       Date:  1988-03
  8 in total
  7 in total

Review 1.  Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies.

Authors:  Kinga Szigeti; Eva Nelis; James R Lupski
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  Diaphragmatic weakness in hereditary motor and sensory neuropathy.

Authors:  M M Green; C Laroche
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

Review 3.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.

Authors:  Loutfi S Aboussouan; Richard A Lewis; Michael E Shy
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

5.  Respiratory dysfunction in Charcot-Marie-Tooth disease type 1A.

Authors:  Mônica de Carvalho Alcântara; Marcello H Nogueira-Barbosa; Regina Maria França Fernandes; Geruza Alves da Silva; Charles Marques Lourenço; Heide H Sander; Wilson Marques Junior
Journal:  J Neurol       Date:  2015-03-13       Impact factor: 4.849

6.  Lightning strike: a first case of unilateral diaphragmatic paralysis.

Authors:  Timucin Alar; Yildiz Degirmenci; Handan Isin Ozisik Karaman
Journal:  Clin Pract       Date:  2011-11-02

Review 7.  Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review.

Authors:  Abdoulaye Yalcouyé; Kevin Esoh; Landouré Guida; Ambroise Wonkam
Journal:  J Peripher Nerv Syst       Date:  2022-04-05       Impact factor: 5.188

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.